Advertisement
Canada markets open in 1 hour 37 minutes

  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CAD/USD

    0.7309
    -0.0012 (-0.17%)
     

  • CRUDE OIL

    78.27
    -0.21 (-0.27%)
     

  • Bitcoin CAD

    86,886.35
    -861.71 (-0.98%)
     

  • CMC Crypto 200

    1,326.62
    -38.51 (-2.82%)
     

  • GOLD FUTURES

    2,322.70
    -8.50 (-0.36%)
     

  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • NASDAQ futures

    18,154.25
    -41.25 (-0.23%)
     

  • VOLATILITY

    13.56
    +0.07 (+0.52%)
     

  • FTSE

    8,296.75
    +83.26 (+1.01%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • CAD/EUR

    0.6787
    -0.0005 (-0.07%)
     

Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·47 min read
Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript

Additional information regarding these statements and our non-GAAP financial measures is available on our earning release and in our SEC Forms 10-K and 10-Q. To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva's Q1 2023 results and business performance, recent events, and priorities going forward. Joining Richard and Eli on the call today are Sven Dethlefs, Teva's head of North America business; and Dr. Eric Hughes, our head of R&D and chief medical officer.

Continue reading